Yonsei University Health System has launched Connect-DTx, a platform that integrates hospitals, insurers, and medical device manufacturers to seamlessly connect the entire care process. The platform allows for the collection of real-time health data from patients using digital therapeutics (DTx) and hospital EMRs, which can be used to personalize treatments. It also facilitates communication with government regulators and insurers for insurance claims and reviews. The first DTx to be approved in South Korea is Somzz, an insomnia treatment developed by Aimmed. The platform aims to provide convenient and safe access to patient health information and improve personalized medical care based on big data.
Source link
Yonsei University Hospital System kicks off DTx ecosystem
